IO Biotech
IOBT
IOBT
26 hedge funds and large institutions have $25.3M invested in IO Biotech in 2025 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
1.34% less ownership
Funds ownership: 28.94% → 27.6% (-1.3%)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Holders
26
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$27.7K | |
| 2 | +$26K | |
| 3 | +$15K | |
| 4 |
Renaissance Technologies
New York
|
+$14.8K |
| 5 |
TSS
Two Sigma Securities
New York
|
+$11.9K |
Top Sellers
| 1 | -$423K | |
| 2 | -$409K | |
| 3 | -$155K | |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$60.5K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$41.7K |